Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-079810
Filing Date
2025-08-18
Accepted
2025-08-18 16:21:08
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B5 tm2523705d1_424b5.htm 424B5 640550
2 GRAPHIC tm2523705d1_424b5img01.jpg GRAPHIC 12057
3 GRAPHIC tm2523705d1_424b5img03.jpg GRAPHIC 34458
4 GRAPHIC tm2523705d1_424b5img04.jpg GRAPHIC 48369
5 GRAPHIC tm2523705d1_424b5img05.jpg GRAPHIC 22409
6 GRAPHIC tm2523705d1_424b5img05a.jpg GRAPHIC 257897
7 GRAPHIC tm2523705d1_424b5img06.jpg GRAPHIC 10908
8 GRAPHIC tm2523705d1_424b5img07.jpg GRAPHIC 37563
  Complete submission text file 0001104659-25-079810.txt   1222994
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 424B5 | Act: 33 | File No.: 333-280680 | Film No.: 251228175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)